Online Enquiry
Subscribe
Log in / New User
Retrieve Password
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Log In
|
New User Registration
|
Retrieve Password
Log In
News
TheMarket
IndustryNews
RegulatoryNews
GeneralHealth
Legal/IPRNews
Product/R&DNews
API/BulkDrugNews
PeopleintheNews
OtherNews
TopNewsWorldwide
FEATURE ARTICLES
Editorials
Commentaries
ExpertOpinions
Interviews
CaseStudies
CompanyProfiles
Editor'sPicks
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
NHSA Solicits Comments on Drafts of the Working Plan and the Application Guide...
The NHSA issued drafts of the Working Plan for Adjustment of 2024 National Reimbursement Drug List (NRDL) and the Application Guide for Adjustment of 2024 NRDL on June 13...
(6/13/2024)
China's Health Supplements Market: Trends and ... (7/16/2024)
Who Will Acquire Legend Bio for 13B to 15B USD... (7/16/2024)
China's Once-booming Online Healthcare Sector ... (7/15/2024)
Will US Clinical Study Diversity Guidance Clou... (7/15/2024)
China Biopharma Tracker – H1/2024 (PharmaNJ) (7/15/2024)
China's Fast-following Approach Positions It a... (7/15/2024)
Prominence of Asia in Global Pharma Clinical T... (7/12/2024)
Political Change Around China Means Change for... (7/11/2024)
Biopharma Partnership Interest with China Rema... (7/11/2024)
House Speaker Mike Johnson Pledges Vote for BI... (7/10/2024)
China's Pharmaceutical Industry Bets Big on Sm... (7/9/2024)
China's Supreme People's Court Clarifies Prior... (7/9/2024)
U.S. Senators Introduce Bill to Reduce U... (7/16/2024)
NMPA Announces Package Insert Revision o... (7/16/2024)
GenScript's US Unit Legend Biotech Repor... (7/15/2024)
Domestic Developers File for China's Fir... (7/15/2024)
CDE Solicits Comments on the Technical G... (7/15/2024)
Recent Executive Moves (7/12/2024)
NMPA Clears CSPC's RSV Vaccine Candidate... (7/12/2024)
CDE Solicits Public Comments on ICH M14 ... (7/12/2024)
AFT in China Distribution Deal with Hain... (7/12/2024)
Recent Advancements and Challenges in Ce... (7/11/2024)
AusperBio AHB-137 Gains Breakthrough Sta... (7/11/2024)
Sichuan Biokin Pharma Files for US$500M ... (7/11/2024)
Ipsen and ForeseenBio Strike Global Lic... (7/11/2024)
Elevar and Hengrui Aim for Quick Refile ... (7/11/2024)
Eisai's Alzheimer's Drug LEQEMBI (Lecane... (7/11/2024)
China to DeepenHealthcare Reform in 2024 (7/10/2024)
China's Share of Clinical Trials Increas... (7/10/2024)
Novartis Expects to Maintain Double-digi... (7/10/2024)
Review of Chinese Hospital Drug Sales: Market Trends an...
Review of Chinese Pharmaceutical Market Segmentation 20...
IQVIA: Chinese Hospital Drug Market Rose 2.6% in MAT Q1...
Nicholas Hall: Chinese Retail CHC Market Rebounds in 20...
Review of Chinese Retail Pharmacy Market (Offline and O...
U.S. Senators Introduce Bill to Reduce U.S. Dependence ...
GenScript's US Unit Legend Biotech Reportedly Receives ...
AFT in China Distribution Deal with Hainan Haiyao for S...
Eisai's Alzheimer's Drug LEQEMBI (Lecanemab) Approved i...
Ipsen and ForeseenBio Strike Global Licensing Deal fo...
NMPA Announces Package Insert Revision of Spleen Polype...
CDE Solicits Comments on the Technical Guidelines for I...
CDE Solicits Public Comments on ICH M14 and Its Chinese...
MOST Committee Issues the Ethical Guidelines for Human ...
CDE Solicits Comments on the Technical Guidelines for C...
Recent Advancements and Challenges in Cervical Cancer P...
China Initiates New Awareness Campaign to Address Risin...
China to DeepenHealthcare Reform in 2024
China Expands Infectious Disease Direct Reporting Syste...
NHSA Issues the Working Plan and the Application Guide ...
Shanghai Claims IP Protection Advancement in Pharmaceut...
Genscript Denies Party Links
U.S. Congress Seeks FBI Briefing on GenScript Over Pote...
PTAB to Hold Trial in Patent Dispute Involving BeiGene ...
Andao Pharma/Kind Pharma and Fibrogen Settle on IP Disp...
India Mulls New PLI Scheme to Reduce Chinese API Depend...
FDA Criticizes Chinese API Producer for Deceptive Pract...
US Urges Indian Pharma to Distance from China for APIs ...
Chinese Researchers Makes Breakthrough with Paclitaxel ...
Crescent HiTech to Build New API Facility in Bangladesh...
Domestic Developers File for China's First Home-Made Qu...
NMPA Clears CSPC's RSV Vaccine Candidate for Human Clin...
Elevar and Hengrui Aim for Quick Refile of PD-1 Liver C...
AusperBio AHB-137 Gains Breakthrough Status in China fo...
China's Share of Clinical Trials Increases Amid Faster ...
BioAtla and BeiGene Revise Global Deal for Novel Condit...
Pfizer to Absorb Mylan, Creating Global Generic Powerho...
PhRMA Calls for Trade Deals That Force Countries to Pay...
IQVIA: Global Pharma to Grow Slower in the Next Five Ye...
Pfizer and GSK Announce JV to Create a Global Consumer ...
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Official and Executive Moves
Recent Official and Executive Moves
China Introduces Plan for Pudong New Area's Pilot Compr...
Upcoming Event: 2023 Pharma CI USA Conference & Exhibit...
Upcoming Event: 15th Annual Pharma Market Research Conf...
Upcoming Event: 6th International Conference on Emergin...
Upcoming Event: PHARM Connect Congress
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
2023 Order Form + Product Descripti...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WEEKLY e-ALERT(Premium)
WEEKLY e-ALERT(Basic)
GENERAL INFORMATION
TERMS/CONDITIONS OF USE
PRIVACY STATEMENT
JOIN THE MAILING LIST
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit